Publications by authors named "Ali Rihani"

Claim this Profile
P
Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023.
Katherina Aguilera, Oscar Bladh, Ulrika Marking, Nina Greilert Norin, Ali Rihani

Lancet Reg Health Eur· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.
Laura D Gamble, Stefania Purgato, Michelle J Henderson, Simone Di Giacomo, Amanda J Russell, Ali Rihani

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and targeting of selective vulnerability rendered by tamoxifen resistance.
Madhurendra Singh, Xiaolei Zhou, Xinsong Chen, Gema Sanz Santos, Sylvain Peuget, Ali Rihani

Breast Cancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds.
Sylvain Peuget, Jiawei Zhu, Gema Sanz, Madhurendra Singh, Massimiliano Gaetani, Ali Rihani

Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR.
Steve Lefever, Ali Rihani, Joni Van der Meulen, Filip Pattyn, Tom Van Maerken

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.
Marjolijn Renard, Suzanne Vanhauwaert, Marine Vanhomwegen, Ali Rihani, Niels Vandamme

Sci Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.
Ali Rihani, Bram De Wilde, Fjoralba Zeka, Geneviève Laureys, Nadine Francotte

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma.
Ali Rihani, Jo Vandesompele, Frank Speleman, Tom Van Maerken

Cancer Cell Int· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expressed repeat elements improve RT-qPCR normalization across a wide range of zebrafish gene expression studies.
Suzanne Vanhauwaert, Gert Van Peer, Ali Rihani, Els Janssens, Pieter Rondou

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma.
Ali Rihani, Alan Van Goethem, Maté Ongenaert, Sara De Brouwer, Pieter-Jan Volders

Sci Rep· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRBase Tracker: keeping track of microRNA annotation changes.
Gert Van Peer, Steve Lefever, Jasper Anckaert, Anneleen Beckers, Ali Rihani

Database (Oxford)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.
Ali Rihani, Tom Van Maerken, Bram De Wilde, Fjoralba Zeka, Geneviève Laureys

Pediatr Blood Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments.
Ali Rihani, Tom Van Maerken, Filip Pattyn, Gert Van Peer, Anneleen Beckers

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer.
Tom Van Maerken, Ali Rihani, Alan Van Goethem, Anne De Paepe, Frank Speleman

Cancer Lett· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The need for transparency and good practices in the qPCR literature.
Stephen A Bustin, Vladimir Benes, Jeremy Garson, Jan Hellemans, Jim Huggett, Ali Rihani

Nat Methods· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations.
Sarah Vergult, Andrew Dauber, Barbara Delle Chiaie, Elke Van Oudenhove, Marleen Simon, Ali Rihani

Eur J Hum Genet· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3.
Tom Van Maerken, Ali Rihani, Daniel Dreidax, Sarah De Clercq, Nurten Yigit

Mol Cancer Ther· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman, Irina Lambertz, Nurten Yigit, Ali Rihani

J Natl Cancer Inst· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis